HIGH-TITER HIV-1 NEUTRALIZING ANTIBODY-RESPONSE OF RHESUS MACAQUES TO GP160 AND ENV PEPTIDES

被引:10
|
作者
RONCO, J
DEDIEU, JF
MARIE, FN
PINTER, A
KACZOREK, M
GIRARD, M
机构
[1] INST PASTEUR,DEPT VIROL,MOLEC VIROL LAB,CNRS,URA 545,28 RUE DOCTEUR ROUX,F-75724 PARIS 15,FRANCE
[2] PASTEUR MERIEUX SERUMS & VACCINS,PARC IND INCARVILLE,F-27101 VAL DE REUIL,FRANCE
[3] PROTEINE PERFORMANCE,F-75018 PARIS,FRANCE
[4] PUBL HLTH RES INST CITY NEW YORK INC,NEW YORK,NY 10016
关键词
D O I
10.1089/aid.1992.8.1117
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Three groups of four rhesus macaques were immunized twice, one month apart with purified recombinant HIV-1LAI gp160 in the presence of either alum, incomplete Freund's adjuvant (IFA), or SAF-1. Two months later, the animals were injected twice again with a synthetic peptide with the sequence of the principal neutralization determinant (PND) of the HIV-1LAI isolate mixed with the same adjuvants. All animals received a booster injection of gp160 and PND peptide at 6 months. This regimen of immunization induced in the SAF-1 and IFA groups a high-titer neutralizing antibody response that declined progressively over the course of the following 6 months. In contrast, only a weak response was observed in the alum group. Neutralizing antibody titers varied as anti-PND titers, suggesting that they were principally targeted to the PND. A shortened immunization protocol comprising two injections of gp160 at 0 and 1 month followed by one injection of PND peptide at 3 months is suggested as optimal for the induction of high titers of HIV-1 neutralizing antibodies in primates.
引用
收藏
页码:1117 / 1123
页数:7
相关论文
共 50 条
  • [31] LONG-TERM HIGH-TITER NEUTRALIZING ACTIVITY INDUCED BY OCTAMERIC SYNTHETIC HIV-1 ANTIGEN
    WANG, CY
    LOONEY, DJ
    LI, ML
    WALFIELD, AM
    YE, J
    HOSEIN, B
    TAM, JP
    WONGSTAAL, F
    SCIENCE, 1991, 254 (5029) : 285 - 288
  • [32] IMMUNIZATION OF CHIMPANZEES WITH BACULOVIRUS-EXPRESSED HIV-1(IIIB) GP160
    NIGIDA, SM
    BESS, JW
    PYLE, SW
    MOREIN, B
    PUTNEY, SD
    ARTHUR, LO
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (02) : 150 - 151
  • [33] HIV-1 RECOMBINANT GP160 VACCINE GIVEN IN ACCELERATED DOSE SCHEDULES
    GORSE, GJ
    SCHWARTZ, DH
    GRAHAM, BS
    MATTHEWS, TJ
    STABLEIN, DM
    FREY, SE
    BELSHE, RB
    CLEMENTS, ML
    WRIGHT, PF
    EIBL, M
    FAST, PE
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 98 (02): : 178 - 184
  • [34] Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope
    Abernathy, Morgan E.
    Gristick, Harry B.
    Vielmetter, Jost
    Keeffe, Jennifer R.
    Gnanapragasam, Priyanthi N. P.
    Lee, Yu E.
    Escolano, Amelia
    Gautam, Rajeev
    Seaman, Michael S.
    Martin, Malcolm A.
    Nussenzweig, Michel C.
    Bjorkman, Pamela J.
    NPJ VACCINES, 2021, 6 (01)
  • [35] Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope
    Morgan E. Abernathy
    Harry B. Gristick
    Jost Vielmetter
    Jennifer R. Keeffe
    Priyanthi N. P. Gnanapragasam
    Yu E. Lee
    Amelia Escolano
    Rajeev Gautam
    Michael S. Seaman
    Malcolm A. Martin
    Michel C. Nussenzweig
    Pamela J. Bjorkman
    npj Vaccines, 6
  • [36] Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site
    Oliva, R
    Leone, M
    Falcigno, L
    D'Auria, G
    Dettin, M
    Scarinci, C
    Di Bello, C
    Paolillo, L
    CHEMISTRY-A EUROPEAN JOURNAL, 2002, 8 (06) : 1467 - 1473
  • [37] CHARACTERIZATION OF SERUM ANTIBODY-RESPONSES TO RECOMBINANT HIV-1 GP160 VACCINE BY ENZYME-IMMUNOASSAY
    VISCIDI, R
    ELLERBECK, E
    GARRISON, L
    MIDTHUN, K
    CLEMENTS, ML
    CLAYMAN, B
    FERNIE, B
    SMITH, G
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (11) : 1251 - 1256
  • [38] The extracellular processing of HIV-1 envelope glycoprotein gp160 by human plasmin
    Okumura, Y
    Yano, M
    Murakami, M
    Mori, S
    Towatari, T
    Kido, H
    FEBS LETTERS, 1999, 442 (01) : 39 - 42
  • [39] CHARACTERIZATION OF A SOLUBLE, OLIGOMERIC HIV-1 GP160 PROTEIN AS A POTENTIAL IMMUNOGEN
    VANCOTT, TC
    VEIT, SCD
    KALYANARAMAN, V
    EARL, P
    BIRX, DL
    JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 183 (01) : 103 - 117
  • [40] IMMUNOGENICITY OF BACULOVIRUS DERIVED HIV-1 GP160 IN INBRED STRAINS OF MICE
    KENNEDY, RC
    WARREN, RQ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 80 - 80